Skip to main content

Table 1 Patient characteristics

From: Plasma glutamine concentration after intensive care unit discharge: an observational study

 

Gender (male)

Age (years)

SAPS III

LOS (days)

SOFA discharge

Dialysis

Study A (n = 63)

39 (62%)

64 (56,71)

68 (62,80)

9 (7,14)

4 (2,8)

13 (21%)

Study A (n = 49)

31 (63%)

63 (55,72)

68 (60,80)

9 (6,13)

4 (2,7)

10 (20%)

  Survivors (n = 40)

26 (65%)

63 (56,71)

65 (62,74)

9 (6,13)

3 (2,5)

3 (8%)

  Nonsurvivors (n = 23)

13 (56%)

65 (61,71)

71 (64,89)

8 (7,14)

7 (4,9)

10 (43%)

  P value

0.59

0.62

0.042

0.81

0.00085

0.0012

Study B (n = 100)

58 (58%)

65 (56,72)

68 (61,77)

9 (6,14)

4 (2,6)

16 (16%)

Study B (n = 92)

55 (60%)

65 (56,72)

68 (62,78)

9 (6,13)

4 (2,7)

16 (17%)

  Survivors (n = 54)

32 (60%)

65 (56,72)

65 (58,70)

8 (6,11)

3 (2,5)

6 (11%)

  Nonsurvivors (n = 38)

23 (60%)

65 (60,72)

74 (66,88)

10 (6,16)

6 (2,8)

10 (26%)

  P value

1.00

0.74

0.0013

0.15

0.043

0.09

  1. All subjects included in Study A (n = 63) and subjects with post-ICU samples (n = 49), and all subjects included in Study B (n = 100) and subjects with post-ICU samples (n = 92). Comparison of survivors and nonsurvivors was done in each group using Mann-Whitney or Fischer’s exact tests. SAPS III, simplified acute physiology score III; LOS, length of stay; SOFA, sequential organ failure assessment.